BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...of the direction Arena goes in.” Lind declined to discuss its future financial steps.At the Wells Fargo...
BioCentury | Jun 20, 2020
Finance

Forma, Repare shine in first-day performances as biotech IPOs on NASDAQ maintain momentum

...$14-$16 range, raising $100 million for a valuation of $677.5 million. Underwriters are Piper Sandler, Wells Fargo...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...Eli Lilly and Co. (NYSE:LLY) has 10.4%. Underwriters are Cowen, SVB Leerink, Credit Suisse and Wells Fargo...
BioCentury | Oct 31, 2019
Financial News

Oyster Point, RAPT post gains after pricing IPOs at low end of range

...of $349.2 million. The Column Group is its largest shareholder; underwriters are BMO Capital Markets, Wells Fargo...
BioCentury | Jul 22, 2019
Financial News

July 22 Financial Quick Takes: Shanghai's rising STAR; plus Retrotrope and RAPT

...5 million shares at $14-16 on Monday. The offering is underwritten by BofA Merrill Lynch, Wells Fargo...
BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...raise up to $86.3 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Wells Fargo...
BioCentury | Jun 19, 2019
Financial News

June 19 Financial Quick Takes: Stoke rises after IPO; plus Polaris, Woodford, follow-ons

...lost 18% on Tuesday, and slipped another $0.65 (14%) to $4.09 on Wednesday. SVB Leerink, Wells Fargo...
BioCentury | Jun 18, 2019
Financial News

June 18 Financial Quick Takes: Biohaven sinks on fund-raising news; plus IPO trio sets terms

...would raise $70 million and be valued at $342 million. Underwriters are Goldman Sachs, Citigroup, Wells Fargo...
BioCentury | May 31, 2019
Financial News

New IPO filings include Adaptive, Morphic

...up to $86.3 million through its listing underwritten by Jefferies, Cowen, BMO Capital Markets and Wells Fargo...
...Mass.) proposed to raise up to $75 million in an IPO underwritten by Goldman, Citigroup, Wells Fargo...
BioCentury | Apr 17, 2019
Financial News

Turning Point gains after pricing upsized $166.5M IPO

...year of both candidates for solid tumors. The offering's underwriters are Goldman Sachs, SVB Leerink, Wells Fargo...
Items per page:
1 - 10 of 511
BioCentury | Oct 28, 2020
Deals

Out of the Arena: With $56M round, spinout Longboard to house trio of neuroscience programs

...of the direction Arena goes in.” Lind declined to discuss its future financial steps.At the Wells Fargo...
BioCentury | Jun 20, 2020
Finance

Forma, Repare shine in first-day performances as biotech IPOs on NASDAQ maintain momentum

...$14-$16 range, raising $100 million for a valuation of $677.5 million. Underwriters are Piper Sandler, Wells Fargo...
BioCentury | May 25, 2020
Finance

New additions to the IPO queue: Generation Bio, Avidity, Vaxcyte and more

...Eli Lilly and Co. (NYSE:LLY) has 10.4%. Underwriters are Cowen, SVB Leerink, Credit Suisse and Wells Fargo...
BioCentury | Oct 31, 2019
Financial News

Oyster Point, RAPT post gains after pricing IPOs at low end of range

...of $349.2 million. The Column Group is its largest shareholder; underwriters are BMO Capital Markets, Wells Fargo...
BioCentury | Jul 22, 2019
Financial News

July 22 Financial Quick Takes: Shanghai's rising STAR; plus Retrotrope and RAPT

...5 million shares at $14-16 on Monday. The offering is underwritten by BofA Merrill Lynch, Wells Fargo...
BioCentury | Jul 8, 2019
Financial News

On heels of series C extension, RAPT Therapeutics files for IPO

...raise up to $86.3 million in an IPO on NASDAQ underwritten by BofA Merrill Lynch, Wells Fargo...
BioCentury | Jun 19, 2019
Financial News

June 19 Financial Quick Takes: Stoke rises after IPO; plus Polaris, Woodford, follow-ons

...lost 18% on Tuesday, and slipped another $0.65 (14%) to $4.09 on Wednesday. SVB Leerink, Wells Fargo...
BioCentury | Jun 18, 2019
Financial News

June 18 Financial Quick Takes: Biohaven sinks on fund-raising news; plus IPO trio sets terms

...would raise $70 million and be valued at $342 million. Underwriters are Goldman Sachs, Citigroup, Wells Fargo...
BioCentury | May 31, 2019
Financial News

New IPO filings include Adaptive, Morphic

...up to $86.3 million through its listing underwritten by Jefferies, Cowen, BMO Capital Markets and Wells Fargo...
...Mass.) proposed to raise up to $75 million in an IPO underwritten by Goldman, Citigroup, Wells Fargo...
BioCentury | Apr 17, 2019
Financial News

Turning Point gains after pricing upsized $166.5M IPO

...year of both candidates for solid tumors. The offering's underwriters are Goldman Sachs, SVB Leerink, Wells Fargo...
Items per page:
1 - 10 of 511